Shopping Cart
- Remove All
- Your shopping cart is currently empty
14,15-Epoxyeicosatrienoic acid (14,15-EET), derived from Arachidonic acid metabolism, significantly inhibits platelet aggregation in vivo and enhances astrocytic Aβ clearance, making it relevant for Alzheimer's Disease research [1][2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | 14,15-Epoxyeicosatrienoic acid (14,15-EET), derived from Arachidonic acid metabolism, significantly inhibits platelet aggregation in vivo and enhances astrocytic Aβ clearance, making it relevant for Alzheimer's Disease research [1][2]. |
In vitro | 14,15-Epoxyeicosatrienoic acid (0-10 μM) enhances Aβ uptake in primary astrocyte cultures [1]. |
In vivo | 14,15-Epoxyeicosatrienoic acid (0.3 mg/kg i.v.) inhibits platelet aggregation in murine cerebral arterioles [2]. Administration of 14,15-Epoxyeicosatrienoic acid (200 ng/ml) into the hippocampus reverses Aβ deposition in the brains of 6-month-old male FAD mice [1]. |
Alias | 14,15-EET |
Molecular Weight | 320.47 |
Formula | C20H32O3 |
Cas No. | 81276-03-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.